Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-09-07 Sale |
2021-09-09 5:34 pm |
Cabaletta Bio Inc. | CABA | 5AM Ventures V L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
625,000 | $9.7 | $6,062,500 | 2,359,263 (Indirect) |
View |
| 2021-08-02 Purchase |
2021-08-04 9:19 pm |
Rallybio Corp | RLYB | PARMAR KUSH Director |
615,384 | $13 | $7,999,992 | 4,994,878 (Indirect Direct) |
View |
| 2021-04-27 Purchase |
2021-04-29 8:51 pm |
IMPEL NEUROPHARMA INC | IMPL | 5AM Ventures V L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC 10% Owner |
575,000 | $15 | $8,625,000 | 575,000 (Indirect) |
View |
| 2021-02-09 Purchase |
2021-02-09 5:15 pm |
Vor Biopharma Inc. | VOR | PARMAR KUSH Director 10% Owner |
555,555 | $18 | $9,999,990 | 1,875,370 (Indirect Direct) |
View |
| 2021-01-08 Sale |
2021-01-12 5:07 pm |
Cabaletta Bio Inc. | CABA | 5AM Ventures V L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
387,000 | $13 | $5,031,000 | 369,688 (Indirect) |
View |
| 2020-12-29 Sale |
2020-12-31 9:32 pm |
Akouos Inc. | AKUS | PARMAR KUSH Director 10% Owner |
470,000 | $18 | $8,460,000 | 982,453 (Indirect) |
View |
| 2020-12-22 Sale |
2020-12-28 9:37 pm |
Homology Medicines Inc. | FIXX | PARMAR KUSH Director |
500,000 | $12.82 | $6,410,000 | 181,435 (Indirect) |
View |
| 2020-12-14 Sale |
2020-12-16 7:25 pm |
Homology Medicines Inc. | FIXX | PARMAR KUSH Director |
500,000 | $12.25 | $6,125,915 | 201,435 (Indirect) |
View |
| 2020-12-10 Sale |
2020-12-14 5:58 pm |
Cabaletta Bio Inc. | CABA | 5AM Ventures V L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
298,000 | $14.75 | $4,395,500 | 417,629 (Indirect) |
View |
| 2020-10-05 Sale |
2020-10-07 9:30 pm |
Aprea Therapeutics Inc. | APRE | 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC DIEKMAN JOHN D Schwab Andrew J. PARMAR KUSH ROCKLAGE SCOTT M Former 10% holder |
175,000 | $25.3 | $4,427,500 | 2,037,654 (Indirect) |
View |
| 2020-06-30 Purchase |
2020-07-02 4:17 pm |
Akouos Inc. | AKUS | PARMAR KUSH Director 10% Owner |
294,117 | $17 | $4,999,989 | 1,094,101 (Indirect) |
View |
| 2020-06-16 Sale |
2020-06-18 7:22 pm |
Aprea Therapeutics Inc. | APRE | 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D Schwab Andrew J. 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC PARMAR KUSH 10% Owner |
140,000 | $33.3 | $4,662,000 | 313,497 (Indirect) |
View |
| 2020-06-11 Sale |
2020-06-15 9:12 pm |
Aprea Therapeutics Inc. | APRE | 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D Schwab Andrew J. 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC PARMAR KUSH 10% Owner |
245,000 | $28.75 | $7,044,412 | 414,105 (Indirect) |
View |
| 2020-05-19 Sale |
2020-05-21 9:31 pm |
Aprea Therapeutics Inc. | APRE | 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D Schwab Andrew J. 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC PARMAR KUSH 10% Owner |
255,000 | $35.15 | $8,963,250 | 423,905 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-07-28 Other |
2021-08-04 9:19 pm |
N/A N/A |
Rallybio Corp | RLYB | PARMAR KUSH Director |
26,341,690 | $0 | 4,994,878 (Indirect) |
View |
| 2021-07-28 Option Award |
2021-08-04 9:19 pm |
N/A N/A |
Rallybio Corp | RLYB | PARMAR KUSH Director |
13,440 | $0 | 4,994,878 (Direct) |
View |
Ownership |
2021-07-29 7:38 pm |
N/A N/A |
Rallybio Corp | RLYB | PARMAR KUSH Director 10% Owner |
0 | $0 | 3,588,780 (Indirect) |
View |
| 2021-06-24 Option Award |
2021-06-25 4:38 pm |
N/A 2031-06-23 |
Akouos Inc. | AKUS | PARMAR KUSH Director 10% Owner |
16,000 | $0 | 16,000 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-22 5:40 pm |
N/A 2031-06-17 |
Homology Medicines Inc. | FIXX | PARMAR KUSH Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2021-04-27 Conversion |
2021-04-29 8:51 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | 5AM Ventures V L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC 10% Owner |
39,725,924 | $0 | 575,000 (Indirect) |
View |
| 2021-04-27 Conversion |
2021-04-29 8:51 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | 5AM Ventures V L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC 10% Owner |
101,457 | $13.5 | 575,000 (Indirect) |
View |
| 2021-04-22 Other |
2021-04-26 5:55 pm |
N/A 2021-12-31 |
IMPEL NEUROPHARMA INC | IMPL | 5AM Ventures V L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
1,359,799 | $0 | 1,359,799 (Indirect) |
View |
Ownership |
2021-04-22 8:04 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | 5AM Ventures V L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
0 | $0 | 2,208,334 (Indirect) |
View |
| 2021-02-05 Option Award |
2021-02-09 5:15 pm |
N/A 2031-02-04 |
Vor Biopharma Inc. | VOR | PARMAR KUSH Director 10% Owner |
16,900 | $0 | 1,875,370 (Direct) |
View |
| 2021-02-09 Conversion |
2021-02-09 5:15 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | PARMAR KUSH Director 10% Owner |
88,184,384 | $0 | 1,875,370 (Indirect) |
View |
Ownership |
2021-02-04 9:49 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | PARMAR KUSH Director 10% Owner |
0 | $0 | 6,136,874 (Indirect) |
View |
| 2020-11-30 Other |
2020-12-01 5:42 pm |
N/A N/A |
5:01 Acquisition Corp. | FVAM | PARMAR KUSH Co-CEO 10% Owner |
235,932 | $0 | 1,944,068 (Indirect) |
View |
| 2020-11-17 Other |
2020-11-18 4:31 pm |
N/A N/A |
5:01 Acquisition Corp. | FVAM | PARMAR KUSH Co-CEO 10% Owner |
30,000 | $0 | 2,180,000 (Indirect) |
View |
| 2020-11-12 Other |
2020-11-12 5:53 pm |
N/A N/A |
5:01 Acquisition Corp. | FVAM | PARMAR KUSH Co-CEO 10% Owner |
5,126 | $10 | 370,252 (Indirect) |
View |
| 2020-10-16 Other |
2020-10-20 8:42 pm |
N/A N/A |
5:01 Acquisition Corp. | FVAM | PARMAR KUSH Co-CEO 10% Owner |
90,000 | $0 | 2,930,000 (Indirect) |
View |
| 2020-10-16 Other |
2020-10-20 8:42 pm |
N/A N/A |
5:01 Acquisition Corp. | FVAM | PARMAR KUSH Co-CEO 10% Owner |
360,000 | $10 | 2,930,000 (Indirect) |
View |
Ownership |
2020-10-13 5:22 pm |
N/A N/A |
5:01 Acquisition Corp. | FVAM | PARMAR KUSH Co-CEO 10% Owner |
0 | $0 | 2,300,000 (Indirect) |
View |
| 2020-06-30 Conversion |
2020-07-02 4:17 pm |
N/A N/A |
Akouos Inc. | AKUS | PARMAR KUSH Director 10% Owner |
95,171,485 | $0 | 1,094,101 (Indirect) |
View |
Ownership |
2020-06-25 7:13 pm |
N/A N/A |
Akouos Inc. | AKUS | PARMAR KUSH Director 10% Owner |
0 | $0 | 4,311,667 (Indirect) |
View |
| 2020-06-10 Option Award |
2020-06-12 5:31 pm |
N/A 2030-06-10 |
Homology Medicines Inc. | FIXX | PARMAR KUSH Director 10% Owner |
18,000 | $0 | 18,000 (Direct) |
View |